Format

Send to

Choose Destination
See comment in PubMed Commons below
Biotechnol Bioeng. 2016 Jul;113(7):1381-402. doi: 10.1002/bit.25895. Epub 2016 Jan 4.

Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.

Author information

  • 1Department of Bioengineering and Therapeutic Sciences, University of California-San Francisco, San Francisco, California 94158.
  • 2Department of Bioengineering and Therapeutic Sciences, University of California-San Francisco, San Francisco, California 94158. shuvo.roy@ucsf.edu.

Abstract

Macroencapsulation technology has been an attractive topic in the field of treatment for Type 1 diabetes due to mechanical stability, versatility, and retrievability of the macro-capsule design. Macro-capsules can be categorized into extravascular and intravascular devices, in which solute transport relies either on diffusion or convection, respectively. Failure of macroencapsulation strategies can be due to limited regenerative capacity of the encased insulin-producing cells, sub-optimal performance of encapsulation biomaterials, insufficient immunoisolation, excessive blood thrombosis for vascular perfusion devices, and inadequate modes of mass transfer to support cell viability and function. However, significant technical advancements have been achieved in macroencapsulation technology, namely reducing diffusion distance for oxygen and nutrients, using pro-angiogenic factors to increase vascularization for islet engraftment, and optimizing membrane permeability and selectivity to prevent immune attacks from host's body. This review presents an overview of existing macroencapsulation devices and discusses the advances based on tissue-engineering approaches that will stimulate future research and development of macroencapsulation technology. Biotechnol. Bioeng. 2016;113: 1381-1402. © 2015 Wiley Periodicals, Inc.

KEYWORDS:

cells and biomaterials; immunoisolation; islet encapsulation; macroencapsulation devices; micro-electro-mechanical systems (MEMS); type 1 diabetes (T1D)

PMID:
26615050
DOI:
10.1002/bit.25895
[PubMed - in process]

Publication Types

Publication Types

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center